Cargando…
From Bench to Clinic: the Potential of Therapeutic Targeting of the IL-22 Signaling Pathway in Atopic Dermatitis
Atopic dermatitis (AD) is the most common pruritic inflammatory skin disease characterized by thickening of epidermis and dermis as well as by the infiltration of multiple pathogenic polarized T lymphocytes, including Th2, Th17, and Th22 cells. Significant progress has been made to develop targeted...
Autores principales: | Jin, Mirim, Yoon, Juhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312894/ https://www.ncbi.nlm.nih.gov/pubmed/30619628 http://dx.doi.org/10.4110/in.2018.18.e42 |
Ejemplares similares
-
Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis
por: Orfali, Raquel Leao, et al.
Publicado: (2023) -
Targeting IL-4 for the Treatment of Atopic Dermatitis
por: Chiricozzi, Andrea, et al.
Publicado: (2020) -
Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target
por: Zeze, Nahoko, et al.
Publicado: (2022) -
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
por: Tsuji, Gaku, et al.
Publicado: (2023) -
Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis
por: Loh, Tiffany Y, et al.
Publicado: (2020)